RoboCT Technology was Selected as the TOP 10 Innovative Company of China Health
Release time:2023-12-15
Related article
Today, the 8th China Health Industry Summit by Equal Ocean was held in Beijing, during which the "CHS 2023 China Health Industry List" were officially released, and RoboCT was selected as the "TOP 10 Innovative Company of China Health". This summit is guided by the China Industrial Development Promotion Association and hosted by Equal Ocean. With the theme of "Evolutionary Innovation", it focuses on heat topics such as technological innovation, intelligent healthcare, health insurance innovation, and investment value.
Equal Ocean launched the selection activities of the 2023 Medical and Health Industry Innovation List and the Digital Health Industry Vitality List, aiming to select companies, investors and the most leading innovative figures with dynamic and innovative genes in China's health industry, to tap the core strength in medical innovation. The companies on the list have not only achieved breakthrough results in product R&D and technological innovation, but also made bold attempts in business progressions.
As far as RoboCT is concerned, the lower-limb rehab exoskeleton solution focuses more on integrating technology and medical treatment to promote the upgrading and transformation of the medical industry. Through the application of big data, artificial intelligence and other technologies, we can optimize medical processes, improve medical efficiency, reduce medical costs, and make medical services more convenient, efficient and popular. RoboCT's exoskeleton solutions are already highly intelligent, personalized, and customized, and can provide more precise and effective rehabilitation support based on the clothing needs and physical conditions of different users.
RoboCT believes that in the future, with the continuous development of science and technology, the medical industry will continue to face new opportunities and challenges. Using rehabilitation exoskeleton solutions as a carrier, it will be able to promote the upgrading and transformation of the medical industry and make greater contributions to the development of human health.